Literature DB >> 1332037

Growth retardation in glioma cells cocultured with cells overexpressing a gap junction protein.

D Zhu1, G M Kidder, S Caveney, C C Naus.   

Abstract

To examine the role of gap-junctional intercellular communication in controlling cell proliferation, we have transfected C6 glioma cells with connexin 43 cDNA. The growth of transfected clones was dramatically reduced compared with nontransfected glioma cells. To further characterize the role of gap junctions in controlling proliferation, we have examined the growth of C6 cells cocultured with transfected cells overexpressing connexin 43. Although C6 cells grew at their normal rate when cocultured with nontransfected C6 cells, when cocultured with connexin 43-overexpressing cells they displayed a dramatic reduction in growth rate. Furthermore, a significant, dose-dependent reduction in cell proliferation was noted when C6 cells were cultured in medium conditioned by transfected cells. This effect correlated with the level of connexin 43 expression. These results suggest that the decreased cell proliferation rate of transfected cells and C6 cells cultured with them is due to the secretion of a growth inhibitory factor(s) and that the secretion of this factor may be linked to the level of gap junctional intercellular communication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332037      PMCID: PMC50309          DOI: 10.1073/pnas.89.21.10218

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression.

Authors:  I Cornil; D Theodorescu; S Man; M Herlyn; J Jambrosic; R S Kerbel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

Review 2.  Role of inhibition of intercellular communication in carcinogenesis.

Authors:  J E Klaunig; R J Ruch
Journal:  Lab Invest       Date:  1990-02       Impact factor: 5.662

3.  Interaction with normal cells suppresses the transformed phenotype of v-myc-transformed quail muscle cells.

Authors:  S A La Rocca; M Grossi; G Falcone; S Alemà; F Tatò
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

4.  Metastatic capacity and intercellular communication between normal cells and metastatic cell clones derived from a rat mammary carcinoma.

Authors:  J Hamada; N Takeichi; H Kobayashi
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

5.  Permeability of membrane junctions.

Authors:  W R Loewenstein
Journal:  Ann N Y Acad Sci       Date:  1966-07-14       Impact factor: 5.691

6.  Expression of gap junction genes in astrocytes and C6 glioma cells.

Authors:  C C Naus; J F Bechberger; S Caveney; J X Wilson
Journal:  Neurosci Lett       Date:  1991-05-13       Impact factor: 3.046

7.  TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis.

Authors:  M T Jennings; R J Maciunas; R Carver; C C Bascom; P Juneau; K Misulis; H L Moses
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

8.  Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells.

Authors:  G P Dotto; R A Weinberg; A Ariza
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Growth control in cultured 3T3 fibroblasts II. Molecular properties of a fraction enriched in growth inhibitory activity.

Authors:  P A Steck; J Blenis; P G Voss; J L Wang
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

10.  Intercellular calcium signaling via gap junctions in glioma cells.

Authors:  A C Charles; C C Naus; D Zhu; G M Kidder; E R Dirksen; M J Sanderson
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

View more
  23 in total

Review 1.  "...those left behind." Biology and oncology of invasive glioma cells.

Authors:  M E Berens; A Giese
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 2.  Glial connexins and gap junctions in CNS inflammation and disease.

Authors:  Tammy Kielian
Journal:  J Neurochem       Date:  2008-04-10       Impact factor: 5.372

Review 3.  Therapeutic strategies targeting connexins.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

4.  Anti-breast cancer agents, quinolines, targeting gap junction.

Authors:  Julie Bernzweig; Brian Heiniger; Keshar Prasain; Jianyu Lu; Duy H Hua; Thu A Nguyen
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

5.  A role for heterologous gap junctions between melanoma and endothelial cells in metastasis.

Authors:  A Ito; F Katoh; T R Kataoka; M Okada; N Tsubota; H Asada; K Yoshikawa; S Maeda; Y Kitamura; H Yamasaki; H Nojima
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  Gap junction-mediated cell-to-cell communication in bovine and human adrenal cells. A process whereby cells increase their responsiveness to physiological corticotropin concentrations.

Authors:  Y Munari-Silem; M C Lebrethon; I Morand; B Rousset; J M Saez
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.

Authors:  Y Omori; M Mesnil; H Yamasaki
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

8.  Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation.

Authors:  Scott R Johnstone; Jeremy Ross; Michael J Rizzo; Adam C Straub; Paul D Lampe; Norbert Leitinger; Brant E Isakson
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

9.  Dynamics of connexin43 phosphorylation in pp60v-src-transformed cells.

Authors:  G S Goldberg; A F Lau
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

10.  The epidermal growth factor receptor tyrosine kinase phosphorylates connexin32.

Authors:  J A Díez; M Elvira; A Villalobo
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.